help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on May 8, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0157
Molecular Endocrinology Vol. 0, No. 2007 200701571-
doi:10.1210/me.2007-0157
Copyright © 2007 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/8/1893    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bassett, J. H. D.
Right arrow Articles by Williams, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bassett, J. H. D.
Right arrow Articles by Williams, G. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene

Submitted on March 27, 2007
Accepted on May 3, 2007

Thyroid status during skeletal development determines adult bone structure and mineralization

J. H. Duncan Bassett, Kristina Nordström, Alan Boyde, Peter G.T. Howell, Shane Kelly, Björn Vennström, and Graham R. Williams*

Molecular Endocrinology Group, Division of Medicine & Medical Research Council Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK; Department of Cell and Molecular Biology, Karolinska Institute, S-171 77, Stockholm, Sweden; Biophysics Oral Growth and Development, Institute of Dentistry, Bart's and The London School of Medicine, Queen Mary University of London, London, E1 1BB, UK; Department of Prosthetic Dentistry, Eastman Dental Institute, University College London, London, WC1X 8LD, UK

* To whom correspondence should be addressed. E-mail: graham.williams{at}ic.ac.uk.

Childhood hypothyroidism delays ossification and bone mineralization whereas adult thyrotoxicosis causes osteoporosis. To determine how effects of thyroid hormone (T3) during development manifest in adult bone, we characterized TR{alpha}1+/m{beta}+/- mice, which express a mutant T3-receptor (TR) {alpha}1 with dominant-negative properties due to reduced ligand-binding affinity. Remarkably, adult TR{alpha}1+/m{beta}+/- mice had osteosclerosis with increased bone mineralization even though juveniles had delayed ossification. This phenotype was partially normalized by transient T3-treatment of juveniles and fully reversed in compound TR{alpha}1+/m{beta}-/- mutant mice due to 10-fold elevated hormone levels that allow the mutant TR{alpha}1 to bind T3. By contrast, deletion of TR{beta} in TR{alpha}1+/+{beta}-/- mice, which causes a 3-fold increase of hormone levels, led to osteoporosis in adults but advanced ossification in juveniles. T3-target gene analysis revealed skeletal hypothyroidism in TR{alpha}1m/+{beta}+/- mice, thyrotoxicosis in TR{alpha}1+/+{beta}-/- mice and euthyroidism in TR{alpha}1+/m{beta}-/- double mutants. Thus, TR{alpha}1 regulates both skeletal development and adult bone maintenance, with euthyroid status during development being essential to establish normal adult bone structure and mineralization.
Key words: Thyroid hormone receptor {alpha}1 • skeletal development • bone mineralization • osteoporosis • T3

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ
Ligands:   Thyroid hormone



This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
K. A Heemstra, W. M van der Deure, R. P Peeters, N. A Hamdy, M. P Stokkel, E. P Corssmit, J. A Romijn, T. J Visser, and J. W Smit
Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.
Eur. J. Endocrinol., July 1, 2008; 159(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Yamoah, A. Brebene, R. Baliram, K. Inagaki, G. Dolios, A. Arabi, R. Majeed, H. Amano, R. Wang, R. Yanagisawa, et al.
High-Mobility Group Box Proteins Modulate Tumor Necrosis Factor-{alpha} Expression in Osteoclastogenesis via a Novel Deoxyribonucleic Acid Sequence
Mol. Endocrinol., May 1, 2008; 22(5): 1141 - 1153.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. D. Bassett, A. J. Williams, E. Murphy, A. Boyde, P. G. T. Howell, R. Swinhoe, M. Archanco, F. Flamant, J. Samarut, S. Costagliola, et al.
A Lack of Thyroid Hormones Rather than Excess Thyrotropin Causes Abnormal Skeletal Development in Hypothyroidism
Mol. Endocrinol., February 1, 2008; 22(2): 501 - 512.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society